Takeda Pharmaceutical Company Limited Other Comprehensive Income Before Tax Cash Flow Hedges
Takeda Pharmaceutical Company Limited (TAK) reported Other Comprehensive Income Before Tax Cash Flow Hedges of -JPY 2.83 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeBeforeTaxCashFlowHedges · last filed 2025-06-25
| Period end | Other Comprehensive Income Before Tax Cash Flow Hedges 12 month |
|---|---|
| 2025-03-31 | -2.83B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 33.79B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | -30.90B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 3.46B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | -65.32B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -37.01B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -34.43B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 2.78B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 6.84B JPY 20-F · filed 2019-06-27 |